A Multi-Center, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety of AC-170 Ophthalmic Solution
PHASE3CompletedINTERVENTIONAL
Enrollment
516
Participants
Timeline
Start Date
April 30, 2016
Primary Completion Date
August 31, 2016
Study Completion Date
August 31, 2016
Conditions
Healthy Subjects
Interventions
DRUG
AC-170 0.24%
DRUG
AC-170 Vehicle
Trial Locations (1)
01810
Ora Clinical Site Network, Andover
All Listed Sponsors
collaborator
ORA, Inc.
INDUSTRY
lead
Nicox Ophthalmics, Inc.
INDUSTRY
NCT02756624 - A Multi-Center, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety of AC-170 Ophthalmic Solution | Biotech Hunter | Biotech Hunter